Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the pojo-accessibility domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/wwwclexiocom/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/wwwclexiocom/wp-includes/functions.php on line 6121
Clexio Biosciences Ltd.

Advancing Novel Therapies
in Neuropsychiatry
for lives worth living

For patients who have not found effective solutions
for their neurological or psychiatric conditions

Clexio Biosciences is a CNS-first clinical stage company. We are dedicated to developing novel therapies for patients suffering from neurological and psychiatric conditions.

Learn More

Aligning humanity, science and technological innovation
to generate new patient-centric possibilities

We identify points of convergence between patients' needs, validated mechanisms of action and technology, to generate new solutions that can be integrated into patients’ lives.

More Info

A multi-asset pipeline

We are a multi-asset company with a rich and growing pipeline, from preclinical to Phase 2 development stages. We invent new therapeutic modalities, and bring them quickly from an idea to Proof of Concept and then to full clinical development.

Program
Pre clinical
Phase 1
Phase 2
Phase 3

CLE-905
M1/M4 muscarinic
agonist

CLE-901
Novel NMDA
antagonist

Quick facts

Solid foundations

Started in 2018 with strong financial backing and a broad network of partners worldwide

Driven by the patients

Technological and therapeutic ingenuity to address patients'
unmet needs

Multidisciplinary team

Broad experience in Pharma & Biotech, from early innovation to clinical development & regulatory approvals

Skip to content